NCT06732401 2026-03-18Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung CancerNational Cancer Institute (NCI)Phase 3 Suspended630 enrolled